8 Coupons
-
Special Offer
-
30% off
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
related stories
-
.
advertisement
originally published on may 17, 2018 10:46 pm
.